Skip to content

IRIDEX CORP

IRIX

CIK 0001006045 · Electromedical & Electrotherapeutic Apparatus · Nasdaq

← back to feed
Revenue (TTM)
$49.75M
+8.2% YoY Q1 May 2026
Net Income (TTM)
−$4.78M
+50.2% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.28
+51.9% YoY Q1 May 2026
Gross Margin
37.2%
Q1 May 2026
Operating Margin
-5.8%
Q1 May 2026
Net Margin
-9.6%
Q1 May 2026
Free Cash Flow (TTM)
−$7.13M
Q1 May 2026
Cash
$4.6M
Q1 May 2026
Total Debt
$2.7M
Q1 May 2026
Shares Outstanding
17.41M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings